donepezil and huprine y

donepezil has been researched along with huprine y in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Kumar, A; Mishra, P; Panda, G	1
Andrisano, V; Arce, EM; Barenys, M; Bartolini, M; Bolognesi, ML; Brea, J; De Simone, A; Decker, M; Ginex, T; Gómez-Catalán, J; Griñán-Ferré, C; Loza, MI; Luque, FJ; Martínez, N; Mattellone, A; Muñoz-Torrero, D; Naldi, M; Pallàs, M; Pérez, B; Pont, C; Sabate, R; Scheiner, M; Soriano-Fernández, Y	1
Brunner, D; Camps, P; Cassina, M; Colantuono, D; Diomede, L; Franco, P; Galdeano, C; Gómez, T; Hutter-Paier, B; Muñoz-Torrero, D; Robin, D; Romeo, M; Salmona, M; Schaeffer, M; Sola, I; Taub, N; Viayna, E	1

Reviews

1 review(s) available for donepezil and huprine y

Article	Year
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018). Bioorganic & medicinal chemistry, 2019, 03-15, Volume: 27, Issue:6 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents	2019

Other Studies

2 other study(ies) available for donepezil and huprine y

Article	Year
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects. European journal of medicinal chemistry, 2021, Dec-05, Volume: 225 Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Brain; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Dynamics Simulation; Molecular Structure; Neuroprotective Agents; Recombinant Proteins; Structure-Activity Relationship; tau Proteins	2021
Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound. Molecules (Basel, Switzerland), 2015, Mar-10, Volume: 20, Issue:3 Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Protein Precursor; Animals; Animals, Genetically Modified; Brain; Caenorhabditis elegans; Disease Models, Animal; Donepezil; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Indans; Mice; Molecular Structure; Piperidines	2015

Article

Year

From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.

European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Brain; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Dynamics Simulation; Molecular Structure; Neuroprotective Agents; Recombinant Proteins; Structure-Activity Relationship; tau Proteins

2021

Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound.

Molecules (Basel, Switzerland), 2015, Mar-10, Volume: 20, Issue:3

Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Protein Precursor; Animals; Animals, Genetically Modified; Brain; Caenorhabditis elegans; Disease Models, Animal; Donepezil; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Indans; Mice; Molecular Structure; Piperidines

2015